161 related articles for article (PubMed ID: 7826898)
21. The treatment of hairy cell leukemia: an update.
Golomb HM; Ratain MJ; Mick R; Daly K
Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
[TBL] [Abstract][Full Text] [Related]
22. Hairy cell leukaemia.
Platanias LC; Golomb HM
Baillieres Clin Haematol; 1993 Dec; 6(4):887-98. PubMed ID: 7913637
[TBL] [Abstract][Full Text] [Related]
23. Hairy cell leukaemia, its therapy and prognosis (historical review with own experiences).
Chrobák L; Podzimek K; Zak P; Plísková L; Voglová J
Acta Haematol Pol; 1995; 26(2 Suppl 1):56-62. PubMed ID: 7653236
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
25. Left behind: should minimal residual disease be treated in hairy cell leukemia?
Park JH; Tallman MS
Leuk Lymphoma; 2014 May; 55(5):971-2. PubMed ID: 24512318
[No Abstract] [Full Text] [Related]
26. Cross-resistance to purine analogs in hairy cell leukemia.
Kraut EH
Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
[No Abstract] [Full Text] [Related]
27. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
[No Abstract] [Full Text] [Related]
28. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment.
Fietz T; Rieger K; Schmittel A; Thiel E; Knauf W
Hematol J; 2004; 5(5):451-2. PubMed ID: 15448675
[No Abstract] [Full Text] [Related]
29. Pleural involvement in hairy cell leukemia--development under alpha-interferon and remission upon pentostatin therapy.
Ho AD; Reichardt P; Gamm H; Hunstein W
Leukemia; 1990 Oct; 4(10):720-1. PubMed ID: 2214876
[No Abstract] [Full Text] [Related]
30. Long-term follow-up studies in hairy cell leukemia.
Grever MR; Zinzani PL
Leuk Lymphoma; 2009 Oct; 50 Suppl 1():23-6. PubMed ID: 19814694
[TBL] [Abstract][Full Text] [Related]
31. Hairy cell leukemia 1992.
Spielberger RT; Golomb HM
Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
[TBL] [Abstract][Full Text] [Related]
32. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
Polliack A
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():41-51. PubMed ID: 9570679
[TBL] [Abstract][Full Text] [Related]
33. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
35. Hairy cell leukemia. Current management.
Doane LL; Ratain MJ; Golomb HM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
[TBL] [Abstract][Full Text] [Related]
36. Chemoimmunotherapy for hairy cell leukemia.
Ravandi F
Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Outcomes of Hairy Cell Leukemia Treated With Purine Analogs: A Comparison With the General Population.
Madanat YF; Rybicki L; Radivoyevitch T; Jagadeesh D; Dean R; Pohlman B; Kalaycio M; Sekeres MA; Smith MR; Hill BT
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):857-862. PubMed ID: 28778620
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia.
Dearden C
Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
[No Abstract] [Full Text] [Related]
39. Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom.
Guest JF; Smith H; Sladkevicius E; Jackson G
Clin Ther; 2009; 31 Pt 2():2398-415. PubMed ID: 20110049
[TBL] [Abstract][Full Text] [Related]
40. Risk of additional cancers in untreated and treated hairy cell leukemia patients.
Dasanu CA; Alexandrescu DT
Expert Opin Pharmacother; 2010 Jan; 11(1):41-50. PubMed ID: 20001428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]